ConductScience.org, home

Paper793499

Failure of customary treatment in chronic active liver disease: causes and management.

Schalm SW and 2 others. Ann Clin Res, 1976. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. Failure of customary treatment in chronic active liver disease: causes and management. Papers, record 793499. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/793499

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Failure of customary treatment in chronic active liver disease: causes and management.
PubMed
Journal
Ann Clin Res
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
3.12
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schalm SWS W
2Ammon HVH V
3Summerskill WHW H

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzathioprineMajor topic
Liver DiseasesMajor topic
PrednisoneMajor topic
Chronic Disease
Clinical Trials as Topic
Drug Therapy, Combination
Evaluation Studies as Topic
Humans
Prognosis
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
33942203The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.Hepatol Int2021https://conductscience.org/library/papers/33942203PubMed
32328366Type 2 Autoimmune Hepatitis in a Male Patient with a Rare Complication of Vasculitis.Cureus2020https://conductscience.org/library/papers/32328366PubMed
30264737The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis.Saudi J Gastroenterol2018https://conductscience.org/library/papers/30264737PubMed
26934884Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.Gut Liver2016https://conductscience.org/library/papers/26934884PubMed
23090425Acute and acute severe (fulminant) autoimmune hepatitis.Dig Dis Sci2013https://conductscience.org/library/papers/23090425PubMed
22966483Liver transplantation in adults: Choosing the appropriate timing.World J Gastrointest Pharmacol Ther2012https://conductscience.org/library/papers/22966483PubMed
22476586Advances in the current treatment of autoimmune hepatitis.Dig Dis Sci2012https://conductscience.org/library/papers/22476586PubMed
21151634A Case of Autoimmune Hepatitis Treated with Rituximab.Case Rep Gastroenterol2010https://conductscience.org/library/papers/21151634PubMed
20180231Difficult treatment decisions in autoimmune hepatitis.World J Gastroenterol2010https://conductscience.org/library/papers/20180231PubMed
19452572Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.World J Gastroenterol2009https://conductscience.org/library/papers/19452572PubMed
18748192Prognostic determinants in chronic hepatitis B infection-a reevaluation.West J Med1978https://conductscience.org/library/papers/18748192PubMed
18414714The use of budesonide in the treatment of autoimmune hepatitis in Canada.Can J Gastroenterol2008https://conductscience.org/library/papers/18414714PubMed
18331074Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.Drugs Aging2008https://conductscience.org/library/papers/18331074PubMed
16313866Autoimmune hepatitis.Curr Treat Options Gastroenterol2005https://conductscience.org/library/papers/16313866PubMed
9951951Drug therapy in the management of type 1 autoimmune hepatitis.Drugs1999https://conductscience.org/library/papers/9951951PubMed
8601374Validation of scoring system for diagnosis of autoimmune hepatitis.Dig Dis Sci1996https://conductscience.org/library/papers/8601374PubMed
7537444Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.Am J Gastroenterol1995https://conductscience.org/library/papers/7537444PubMed
7140120Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease.Clin Pharmacokinet1982https://conductscience.org/library/papers/7140120PubMed
7002738Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance.Gut1980https://conductscience.org/library/papers/7002738PubMed
383357Corticosteroid pharmacokinetics in liver disease.Clin Pharmacokinet1979https://conductscience.org/library/papers/383357PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/793499

GET https://conductscience.org/api/papers/v1/793499/cited_by?page=2